218930-10-0

Usage

Uses

Used in Pharmaceutical Production:
4-(2,6-DIMETHYLMORPHOLINO)ANILINE, TECH is used as an intermediate in the synthesis of pharmaceuticals for its ability to contribute to the development of new medicinal compounds.
Used in Dye Manufacturing:
In the dye industry, 4-(2,6-DIMETHYLMORPHOLINO)ANILINE, TECH serves as a key intermediate, playing a crucial role in the production of various dyes due to its chemical properties that facilitate color development.
Used in Pesticide Synthesis:
4-(2,6-DIMETHYLMORPHOLINO)ANILINE, TECH is utilized as a component in the creation of pesticides, where it aids in the formation of active ingredients that help control, repel, or kill pests.
Used in Rubber Accelerator Production:
4-(2,6-DIMETHYLMORPHOLINO)ANILINE, TECH is employed as an intermediate in the production of rubber accelerators, which are essential for enhancing the rate of vulcanization in rubber manufacturing processes.
Used in UV Stabilizer Synthesis:
4-(2,6-DIMETHYLMORPHOLINO)ANILINE, TECH is used in the synthesis of UV stabilizers, which are additives in plastics and other materials to protect them from degradation caused by ultraviolet light exposure.
Potential Use in Organic Electronics:
4-(2,6-DIMETHYLMORPHOLINO)ANILINE, TECH may have potential applications in the field of organic electronics, where its unique chemical structure could contribute to the development of new electronic components or materials.
Potential Use as a Building Block for Advanced Materials:
DMTA could also be used as a building block for constructing advanced materials, given its chemical properties that may allow for the creation of novel materials with specific functionalities or improved performance in various applications.

InChI:InChI=1/C12H18N2O/c1-9-7-14(8-10(2)15-9)12-5-3-11(13)4-6-12/h3-6,9-10H,7-8,13H2,1-2H3

Upstream product

• 141-91-3 2,6-dimethyl morpholine 
• 350-46-9 4-Fluoronitrobenzene 
• 29842-64-6 2,6-dimethyl-4-(4-nitrophenyl)morpholine 

Downstream Products

• 442548-64-3 6-Methoxy-8-(4-methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid [4-(2,6-dimethyl-morpholin-4-yl)-phenyl]-amide 

Relevant academic research and scientific papers

SUBSTITUTED HETEROCYCLIC AMINE DERIVATIVES AS MULTIKINASE INHIBITORS FOR THE TREATMENT OF CANCER

The present invention relates to compounds of formula (I), their isotopic forms, stereoisomeric forms, tautomeric forms, pharmaceutically acceptable salts, pharmaceutically acceptable solvates, prodrugs, polymorphs or N-oxides thereof. The present invention also relates to processes for the preparation of compounds of formula (I) and pharmaceutical compositions comprising the compounds of formula (I). The compounds and their pharmaceutical compositions are multikinase inhibitors and are useful in the treatment of proliferative disorders, such as cancers.

VEGFR TYROSINE KINASE INHIBITORS

Novel compounds, their prodrugs, and the pharmaceutically acceptable salts as pharmaceutical compositions containing such compounds useful in treating certain diseases modulated by the inhibition of vascular endothelial growth factors (VEGFs) receptor tyrosine kinases are provided. In particular, compounds and compositions and the methods for the prophylaxis, management and treatment of cancers through the inhibition of VEGF receptor tyrosine kinases are provided.

Aminoalkyl-substituted aromatic bicyclic compounds, methods for their preparation and their use as pharmaceuticals

The present invention relates to aminoalkyl-substituted aromatic bicyclic compounds of formula I, which are valuable pharmaceutically active compounds that are suitable, for example, for the treatment of obesity, type II diabetes, arteriosclerosis, high blood pressure, paresthesia, depression, anxiety, anxiety neuroses, schizophrenia, disorders associated with the circadian rhythm, and drug abuse, as well as normalizing lipid metabolism.